Additionally, this type of BC has a high expression of genes and proteins, such as the ERBB2/HER2neu gene and the growth factor receptor bound protein 7, which are related to proliferation, angiogenesis, and invasion of tumor cells, hence HER2-enriched BC patients have lower progression-free survival (PFS) [3]. This evidence concerns the gene ERBB2 and breast cancer.